Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products
(2002; 52 pages) Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentChapter 1 - Introduction
Afficher le documentChapter 2 - A Short History of Involvement in Drug Safety Monitoring by WHO
Afficher le documentChapter 3 - Partners in Pharmacovigilance
Afficher le documentChapter 4 - Pharmacovigilance in Drug Regulation
Afficher le documentChapter 5 - Pharmacovigilance in Clinical Practice
Afficher le documentChapter 6 - Pharmacovigilance in International Health
Afficher le documentChapter 7 - Conclusion and considerations for the future
Afficher le documentGlossary
Afficher le documentReferences
Afficher le documentBack Cover
 

The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products

World Health Organization 2002

WHO Collaborating Centre for International Drug Monitoring

WHO Library Cataloguing-in-Publication Data

The Importance of Pharmacovigilance. (Safety monitoring of medicinal products)

1. Drug monitoring
2. Pharmaceutical preparations - adverse effects
3. Adverse drug reaction reporting
4. Product surveillance, Postmarketing
5. Legislation, Drug I.Series


ISBN 92 4 159015 7 (NLM classification: QV 38)

The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available.

© World Health Organization 2002

Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

Typeset and printed in the United Kingdom.

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 7 octobre 2014